<?xml version="1.0" encoding="UTF-8"?>
<feed xmlns="http://www.w3.org/2005/Atom">
  <id>https://recalls.watch/feed/substance-lacosamide.xml</id>
  <title>Recalls Watch: Lacosamide</title>
  <link rel="self" href="https://recalls.watch/feed/substance-lacosamide.xml"/>
  <link href="https://recalls.watch/alerts/"/>
  <updated>2026-07-01T00:00:00Z</updated>
  <entry>
    <id>https://recalls.watch/recall/fda/99200/</id>
    <title>Annora Pharma Private Limited: Lacosamide Tablets</title>
    <link href="https://recalls.watch/recall/fda/99200/"/>
    <updated>2026-07-01T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Presence of a Foreign Tablets: Complaint received, possible mix-up of Selexipag 1000 mcg tablet in a bottle of Lacosamide Tablets USP, 100mg.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96953/</id>
    <title>Apotex Corp.: Lacosamide Oral Solution</title>
    <link href="https://recalls.watch/recall/fda/96953/"/>
    <updated>2025-06-11T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: Defective Container: This recall is being initiated due to a leaking unit stored horizontally.</summary>
  </entry>
  <entry>
    <id>https://recalls.watch/recall/fda/96474/</id>
    <title>Glenmark Pharmaceuticals Inc., USA: Fenofibrate Capsules 67 mg and 38 more</title>
    <link href="https://recalls.watch/recall/fda/96474/"/>
    <updated>2025-04-16T12:00:00Z</updated>
    <category term="drugs"/>
    <summary>FDA: CGMP Deviations</summary>
  </entry>
</feed>
